Back

Morgagni-Adam-Stokes syndrome as first manifestation of Anderson-Fabry disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: challenges in diagnosis and treatments Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Giulia Marchionni

Umberto I Hospital, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
Hypertrophic cardiomyopathy in a Mexican female with Fabry disease: challenges in multidisciplinary diagnosis. family with novel pathogenic GLA gene variants.
Doctor J. Garcia Diaz (Zapopan, MX)
Slides Video
Presentation thumbnail
Utilising mavacamten to mitigate post TAVR suicide left ventricle risk in patient with concomitant severe aortic stenosis, hypertrophic obstructive cardiomyopathy, and severe coronary artery disease.
Doctor C. Mew (Brisbane, AU)
Slides Video
Presentation thumbnail
Red flags plays a significant role in the diagnosis of Anderson–Fabry disease
Miss A. Yang (Hangzhou, CN)
Slides Video
Presentation thumbnail
Connecting the dots in a young patient with left ventricular hypertrophy, diabetes and deafness
Doctor A. Papageorgiou (Athens, GR)
Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: challenges in diagnosis and treatments
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Hypertrophic cardiomyopathy: challenges in diagnosis and treatments
thumbnail
Congress Presentation
Red flags plays a significant role in the diagnosis of Anderson–Fabry disease
thumbnail
Congress Session
The zebras of hypertrophic cardiomyopathy: rare and challenging

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources